Patents by Inventor Shinya Ogawa
Shinya Ogawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240160230Abstract: The flow rate control device 10 includes a control valve 11, a restriction part 12 provided downstream of the control valve 11, an upstream pressure sensor 13 for measuring a pressure P1 between the control valve 11 and the restriction part 12, a differential pressure sensor 20 for measuring a differential pressure ?P between the upstream and the downstream of the restriction part 12, and an arithmetic control circuit 16 connected to the control valve 11, the upstream pressure sensor 13, and the differential pressure sensor 20.Type: ApplicationFiled: January 22, 2024Publication date: May 16, 2024Applicant: FUJIKIN INCORPORATEDInventors: Kaoru HIRATA, Keisuke IDEGUCHI, Shinya OGAWA, Katsuyuki SUGITA, Masaaki NAGASE, Kouji NISHINO, Nobukazu IKEDA, Hiroyuki ITO
-
Publication number: 20240160216Abstract: A vehicle control system includes: a vehicle including an operation device; a first communication device; and a second communication device. In a case in which the first communication device is positioned in a first area containing a position of the vehicle, the vehicle operates in an operation waiting state in which the operation device is allowed to receive an operation. In a case in which the second communication device is positioned in a second area contained in the first area and smaller than the first area, the vehicle operates in the operation waiting state. In a case in which the first communication device is positioned in the first area and the second communication device is positioned in the second area, the second communication device generates a notification indicating that the vehicle is in the operation waiting state.Type: ApplicationFiled: January 23, 2024Publication date: May 16, 2024Applicant: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.Inventors: Jun FUJIYAMA, Naoya KOIKE, Jun OGAWA, Shinya OTA
-
Patent number: 11985533Abstract: There are provided a plurality of radio devices detecting an interference source signal transmitted by an interference source and generating pieces of air time information showing whether the interference source signal exists or not for each predetermined time unit; and an aggregation device estimating air time of the interference source by acquiring the pieces of air time information from the plurality of radio devices and aggregating/integrating the acquired pieces of air time information for each predetermined unit time, matching timings.Type: GrantFiled: September 13, 2019Date of Patent: May 14, 2024Assignee: Nippon Telegraph and Telephone CorporationInventors: Junichi Iwatani, Hiroyuki Nakamura, Tomoaki Ogawa, Makoto Umeuchi, Shinya Otsuki, Hiroshi Sakamoto, Masayoshi Nabeshima
-
Patent number: 11985529Abstract: A plurality of access points configured to communicate with a subordinate wireless LAN terminal, an information collecting device configured to collect a frame respectively transmitted and received between the plurality of access points and the wireless LAN terminal, and extract information on communication quality of an access point of the plurality of access points from a header of the frame, and an information collecting server configured to acquire the information on the communication quality of the access point from the information collecting device, analyze the information to determine whether the communication quality is good or bad for each of the plurality of access points, and execute processing of externally displaying or notifying a result that is determined are included.Type: GrantFiled: October 18, 2019Date of Patent: May 14, 2024Assignee: Nippon Telegraph and Telephone CorporationInventors: Masayoshi Nabeshima, Hiroyuki Nakamura, Tomoaki Ogawa, Shinya Otsuki, Makoto Umeuchi, Junichi Iwatani, Hiroshi Sakamoto
-
Patent number: 11970531Abstract: An object of the present invention is to provide an anti-BMP10 antibody, and a therapeutic agent for hypertension and a hypertensive disease, containing the antibody as an active ingredient. The present invention relates to an anti-BMP10 monoclonal antibody or an antibody fragment thereof that binds to human BMP10 (bone morphogenetic protein 10). Further, the present invention relates to a therapeutic agent for hypertension and a hypertensive disease containing an antagonist for at least one of BMP10 and a BMP9/BMP10 heterodimer, a diagnostic agent or a pharmaceutical composition for a disease associated with human BMP10, an immunological detection method or a measurement method for human BMP10 using the antagonist, and use of the antagonist for producing a pharmaceutical composition for treating hypertension and a hypertensive disease.Type: GrantFiled: September 27, 2022Date of Patent: April 30, 2024Assignee: KYOWA KIRIN CO., LTD.Inventors: Hiroyuki Ariyama, Shinya Ogawa, Tetsuya Kitayama, Takenao Yamada
-
Patent number: 11951874Abstract: A vehicle driving system that can suppress a difference in effect of vehicle attitude control between the cases where a friction braking force is applied and not applied, is provided. The system includes a rotating electric machine, a battery, a steering apparatus, a steering angle sensor, a brake actuator that applies a friction braking force, a friction braking force sensor, and a controller that sets a deceleration torque based on a steering speed detected by the steering angle sensor and controls the rotating electric machine to apply the deceleration torque to a front wheel of the vehicle, thereby executing a vehicle attitude control. When the friction braking force is applied to the wheels by the brake actuator during the vehicle attitude control, if the friction braking force is large, the controller corrects the deceleration torque to a larger value than when the friction braking force is small.Type: GrantFiled: June 23, 2021Date of Patent: April 9, 2024Assignee: Mazda Motor CorporationInventors: Daisaku Ogawa, Daisuke Umetsu, Shinya Morishita
-
Publication number: 20240075789Abstract: A control device includes a controller that executes determining a connection between a first unit that has a boarding space which allows a user to board and is provided with a predetermined facility and that is provided with a first path through which a fluid used in the predetermined facility passes and a second unit that is configured to be separated from and connected to the first unit and that has a drive device of a vehicle that is formed by being connected to the first unit, and supplying the fluid in the first path to a second unit side to absorb heat generated from the drive device.Type: ApplicationFiled: November 10, 2023Publication date: March 7, 2024Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHAInventors: Toshinari OGAWA, Kohta TARAO, Shinya KIJIMA, Osamu FUKAWATASE, Koji YASUI, Toshiyuki KOBAYASHI, Hitomi NAKATANI, Kuniaki JINNAI, Nobuki HAYASHI, Masahiro NAGANO, Akihiro ITO
-
Patent number: 11921094Abstract: Liquid sent by a liquid sending pump flows through an analysis flow path. A sample is injected into the analysis flow path. A separation column is provided in the analysis flow path. A sample injected in the separation column is separated into components, and sample components obtained by separation are detected by a detector. The number of liquid sending pumps and a connection structure of the liquid sending pumps connected to the analysis flow path are specified by a system configuration specifier as a system configuration. A condition for detecting a liquid sending failure in a liquid sending pump that is preset for each type of system configuration is held by a condition holder. A condition corresponding to a system configuration is determined from conditions held by the condition holder. A liquid sending failure in a liquid sending pump is detected with use of the determined condition.Type: GrantFiled: March 13, 2019Date of Patent: March 5, 2024Assignee: Shimadzu CorporationInventors: Tomohiro Gomi, Daisuke Kitabayashi, Shinya Imamura, Keisuke Ogawa
-
Patent number: 11921518Abstract: A vehicle control system includes: a vehicle including an operation device; a first communication device; and a second communication device. In a case in which the first communication device is positioned in a first area containing a position of the vehicle, the vehicle operates in an operation waiting state in which the operation device is allowed to receive an operation. In a case in which the second communication device is positioned in a second area contained in the first area and smaller than the first area, the vehicle operates in the operation waiting state. In a case in which the first communication device is positioned in the first area and the second communication device is positioned in the second area, the second communication device generates a notification indicating that the vehicle is in the operation waiting state.Type: GrantFiled: June 22, 2021Date of Patent: March 5, 2024Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.Inventors: Jun Fujiyama, Naoya Koike, Jun Ogawa, Shinya Ota
-
Patent number: 11912775Abstract: A monoclonal antibody is provided which binds to a human CC chemokine receptor 1 (CCR1) and inhibits activation of the human CCR1, or an antibody fragment thereof. The monoclonal antibody binds to an extracellular region of a human CCR1 and inhibits activation of the human CCR1 by a human CC chemokine ligand 15 (CCL15). An antibody fragment thereof, a hybridoma producing the antibody, a nucleic acid having a nucleotide sequence encoding the antibody or the antibody fragment, a transformant cell containing a vector containing the nucleic acid, a method for producing the antibody or the antibody fragment using the hybridoma or the transformant cell; a therapeutic agent and a diagnostic agent containing the antibody or the antibody fragment, and a method for treating and diagnosing a CCR1-related disease using the antibody or the antibody fragment are also provided.Type: GrantFiled: July 18, 2018Date of Patent: February 27, 2024Assignees: KYOWA KIRIN CO., LTD., KYOTO UNIVERSITYInventors: Masayuki Kai, Shinya Ogawa, Makoto Taketo, Kenji Kawada, Hideyo Hirai, Yoshiharu Sakai, Taira Maekawa
-
Patent number: 11914407Abstract: The flow rate control device 10 includes a control valve 11, a restriction part 12 provided downstream of the control valve 11, an upstream pressure sensor 13 for measuring a pressure P1 between the control valve 11 and the restriction part 12, a differential pressure sensor 20 for measuring a differential pressure ?P between the upstream and the downstream of the restriction part 12, and an arithmetic control circuit 16 connected to the control valve 11, the upstream pressure sensor 13, and the differential pressure sensor 20.Type: GrantFiled: April 16, 2020Date of Patent: February 27, 2024Assignee: FUJIKIN INCORPORATEDInventors: Kaoru Hirata, Keisuke Ideguchi, Shinya Ogawa, Katsuyuki Sugita, Masaaki Nagase, Kouji Nishino, Nobukazu Ikeda, Hiroyuki Ito
-
Publication number: 20240026017Abstract: A monoclonal antibody is provided which binds to a human CC chemokine receptor 1 (CCR1) and inhibits activation of the human CCR1, or an antibody fragment thereof. The monoclonal antibody binds to an extracellular region of a human CCR1 and inhibits activation of the human CCR1 by a human CC chemokine ligand 15 (CCL15). An antibody fragment thereof, a hybridoma producing the antibody, a nucleic acid having a nucleotide sequence encoding the antibody or the antibody fragment, a transformant cell containing a vector containing the nucleic acid, a method for producing the antibody or the antibody fragment using the hybridoma or the transformant cell; a therapeutic agent and a diagnostic agent containing the antibody or the antibody fragment, and a method for treating and diagnosing a CCR1-related disease using the antibody or the antibody fragment are also provided.Type: ApplicationFiled: September 1, 2023Publication date: January 25, 2024Applicants: Kyowa Kirin Co., Ltd., Kyoto UniversityInventors: Masayuki Kai, Shinya Ogawa, Makoto Taketo, Kenji Kawada, Hideyo Hirai, Yoshiharu Sakai, Taira Maekawa
-
Publication number: 20230406926Abstract: An object of the present invention is to provide a bispecific antibody that binds to CD3 or a bispecific antibody fragment thereof. The present invention relates to a bispecific antibody that binds to CD3 or a bispecific antibody fragment thereof, a DNA encoding the bispecific antibody or the bispecific antibody fragment thereof, a vector containing the DNA, a hybridoma and a transformant that produce the bispecific antibody or the bispecific antibody fragment thereof, a method for producing the bispecific antibody or the bispecific antibody fragment thereof, therapeutic and diagnostic agents containing the bispecific antibody or the bispecific antibody fragment thereof, therapeutic and diagnostic methods using the bispecific antibody or the bispecific antibody fragment thereof, and a reagent for detection or measurement containing the bispecific antibody or the bispecific antibody fragment thereof.Type: ApplicationFiled: February 12, 2021Publication date: December 21, 2023Applicant: Kyowa Kirin Co., Ltd.Inventors: Rinpei NIWA, Shinya OGAWA, Mami WAJIMA, Tsuguo KUBOTA
-
Publication number: 20230359228Abstract: A flow rate control device 100 includes a control valve 6 provided in a flow path 1, a flow rate measurement unit 2, 3 for measuring fluid flow rate controlled by the control valve 6, and a controller 7. The controller 7 is configured so as to control the opening/closing operation of the control valve 6 to match the measurement integral flow rate based on the signal outputted from the flow rate measurement unit (Vn+Vd) to the target integral flow rate Vs.Type: ApplicationFiled: July 3, 2023Publication date: November 9, 2023Applicant: FUJIKIN INCORPORATEDInventors: Katsuyuki SUGITA, Kouji NISHINO, Naofumi YASUMOTO, Kaoru HIRATA, Shinya OGAWA, Keisuke IDEGUCHI
-
Patent number: 11733721Abstract: A flow rate control device 100 includes a control valve 6 provided in a flow path 1, a flow rate measurement unit 2, 3 for measuring fluid flow rate controlled by the control valve 6, and a controller 7. The controller 7 is configured so as to control the opening/closing operation of the control valve 6 to match the measurement integral flow rate based on the signal outputted from the flow rate measurement unit (Vn+Vd) to the target integral flow rate Vs.Type: GrantFiled: February 15, 2019Date of Patent: August 22, 2023Assignee: FUJIKIN INCORPORATEDInventors: Katsuyuki Sugita, Kouji Nishino, Naofumi Yasumoto, Kaoru Hirata, Shinya Ogawa, Keisuke Ideguchi
-
Publication number: 20230129479Abstract: A flow rate control device (8) includes a control valve (6) having a valve element and a piezoelectric element for moving the valve element, and an arithmetic processing circuit (7) for controlling an operation of the control valve, wherein the arithmetic processing circuit is configured to receive an external command signal SE corresponding to a target flow rate when opening the control valve from a closed state so that a gas flows at the target flow rate, and to generate an internal command signal E1 output to a driving circuit for determining a voltage applied to the piezoelectric element based on the external command signal, the internal command signal is a signal that rises with time from zero and converges to a value of the external command signal, and is generated such that a slope at the time of initial rise and a slope immediately before convergence are smaller than a slope therebetween.Type: ApplicationFiled: January 19, 2021Publication date: April 27, 2023Applicant: FUJIKIN INCORPORATEDInventors: Katsuyuki SUGITA, Kouji NISHINO, Kaoru HIRATA, Shinya OGAWA, Keisuke IDEGUCHI
-
Publication number: 20230090939Abstract: An object of the present invention is to provide an anti-BMP10 antibody, and a therapeutic agent for hypertension and a hypertensive disease, containing the antibody as an active ingredient. The present invention relates to an anti-BMP10 monoclonal antibody or an antibody fragment thereof that binds to human BMP10 (bone morphogenetic protein 10). Further, the present invention relates to a therapeutic agent for hypertension and a hypertensive disease containing an antagonist for at least one of BMP10 and a BMP9/BMP10 heterodimer, a diagnostic agent or a pharmaceutical composition for a disease associated with human BMP10, an immunological detection method or a measurement method for human BMP10 using the antagonist, and use of the antagonist for producing a pharmaceutical composition for treating hypertension and a hypertensive disease.Type: ApplicationFiled: September 27, 2022Publication date: March 23, 2023Applicant: Kyowa Kirin Co., Ltd.Inventors: Hiroyuki ARIYAMA, Shinya OGAWA, Tetsuya KITAYAMA, Takenao YAMADA
-
Publication number: 20230011244Abstract: A pressure control device 20 includes a pressure control valve 25, a flow resistance 23 provided downstream of the pressure control valve, for restricting a gas flow, a first pressure sensor 21 for measuring a gas pressure between the pressure control valve and the flow resistance, a second pressure sensor 22 for measuring a gas pressure downstream of the flow resistance, and an arithmetic control circuit 26 connected to the first pressure sensor and the second pressure sensor. The pressure control device is configured to control the gas pressure downstream of the flow resistance by adjusting an opening degree of the pressure control valve based on an output of the second pressure sensor regardless of an output of the first pressure sensor control, and calculate the flow rate of the gas downstream of the flow resistance based on the output of the first pressure sensor and the output of the second pressure sensor.Type: ApplicationFiled: December 3, 2020Publication date: January 12, 2023Applicant: FUJIKIN INCORPORATEDInventors: Kaoru HIRATA, Kouji NISHINO, Katsuyuki SUGITA, Shinya OGAWA, Keisuke IDEGUCHI
-
Publication number: 20220357899Abstract: An image forming apparatus includes a memory, a control device, and an image forming device. The control device includes a processor and functions as a memory manager and a controller through the processor executing a control program. The memory manager allocates amounts of the memory depending on different types of processing constituting a job to create a plurality of memory regions. The controller executes the job using at least one of the plurality of memory regions. The image forming device executes an image forming job of forming an image on a sheet under control of the controller.Type: ApplicationFiled: April 18, 2022Publication date: November 10, 2022Applicant: KYOCERA Document Solutions Inc.Inventors: Shinya OGAWA, Tsuyoshi NITTA, Yasuyuki YABUUCHI, Satoshi HAYAMA, Shinichi HASHIMOTO
-
Patent number: 11485779Abstract: An object of the present invention is to provide an anti-BMP10 antibody, and a therapeutic agent for hypertension and a hypertensive disease, containing the antibody as an active ingredient. The present invention relates to an anti-BMP10 monoclonal antibody or an antibody fragment thereof that binds to human BMP10 (bone morphogenetic protein 10). Further, the present invention relates to a therapeutic agent for hypertension and a hypertensive disease containing an antagonist for at least one of BMP10 and a BMP9/BMP10 heterodimer, a diagnostic agent or a pharmaceutical composition for a disease associated with human BMP10, an immunological detection method or a measurement method for human BMP10 using the antagonist, and use of the antagonist for producing a pharmaceutical composition for treating hypertension and a hypertensive disease.Type: GrantFiled: December 12, 2018Date of Patent: November 1, 2022Assignee: KYOWA KIRIN CO., LTD.Inventors: Hiroyuki Ariyama, Shinya Ogawa, Tetsuya Kitayama, Takenao Yamada